To confirm that MALT1 is indeed a drug target in human CCA cells, MALT1-knockdown HuCCT1 cells were more sensitive to regorafenib when compared with cells transfected with an empty vector (Figure 2B). The gene discussed is MALT1; the disease is cholangiocarcinoma.